INTRODUCTION

Maternal mortality
Taj mahal -One of the Seven Wonders of the World. One of the greatest monuments, dedicated to the memory of -Queen Mumtaz -who died after her last childbirth of postpartum haemorrhage in 1630 -is a testimony to grim reminder of the tragedy of maternal mortality that can befall any woman in childbirth. 1 The World Health Organization states that every minute, at least one woman dies from complication related to pregnancy or childbirth that means 529000 women a year. 2 Developing countries account for 99% (286 000) of the global maternal deaths with sub-Saharan Africa region alone accounting for 62% (179 000) followed by Southern Asia (69 000 Khan et al, using various datasets, estimated that hemorrhage is the main cause of maternal mortality in Asia and Africa -accounting for 30% or more of all maternal deaths. -If mother receives postpartum care as assiduously as they receive prenatal care, maternal mortality would decrease.‖-Li et al in 1996. 5 Atonic PPH is the most common cause of PPH and the leading cause of maternal death. To prevent atonic PPH, interventions should therefore be targeted at all women during childbirth. To reduce blood loss after delivery, the WHO recommends the Active Management of the Third Stage of Labor (AMTSL) be offered to all women delivering with skilled attendants (WHO 2007).
Prevention of PPH 8,9
Reaffirming and Refining Best Practice for PPH Prevention. (WHO 2012 Recommendations) Active management of the third stage of labour (AMTSL) is still a best practice, with the use of uterotonics now the most critical element. Oxytocin remains the uterotonic of choice for AMTSL. Oxytocin (10 IU, IM or IV) is the preferred uterotonic based on studies on the safety and effectiveness of uterotonics. Other elements of AMTSL-controlled cord traction and immediate fundal massage-are optional for PPH prevention. Delayed cord clamping (performed after 1 to 3 minutes after birth) is still recommended for all births to reduce infant anaemia-while beginning essential newborn care at the same time. Postpartum abdominal uterine tonus assessment for early identification of uterine atony is recommended for all women. Compared with physiologic management, active management of the third stage of labor reduced the risk of PPH, the need for blood transfusion, the incidence of prolonged third stage (longer than 30 min), and the need for additional therapeutic uterotonic drugs in all three trials. 10, 11, 12 Assessments of blood loss
13-17
The BRASSS-V drape was developed by the NICHDfunded Global Network UMKC/ JNMC/UIC collaborative team to specifically estimate postpartum blood loss. (The name ‗BRASSS-V' was coined by adding the first letter of the names of the seven collaborators who developed the drape.) The drape has a calibrated and funnelled collecting pouch, incorporated within a plastic sheet that is placed under the buttocks of the patient immediately after the delivery of the baby. Use of the drape diagnosed postpartum haemorrhage four times as often as the visual estimate.
METHODS
The study was conducted at Department of Obstetrics &Gynaecology, P D U Medical College, Rajkot, from 5th Jan 2014 to 4th Jan2015. Ethical committee approval was taken. Low risk women were included in the study.
Inclusion criteria
Normal /low risk patients assigned randomly in age group of 19-35 years. After delivery of baby all fluids/liquor/blood is immediately removed from the delivery table and a fresh specially prepared plastic sheet (brasss-V type) with funnel attached to its lower part replaced by the doctor. He has also collected the specially prepared 10 x 10 cms delivery pads soiled for visual assessment of blood loss. The total blood is collected in calibrated vessel after the delivery of the baby, delivery of placenta and through the 4th stage of labour (1hour).
The frequency of observation of blood loss is grouped in following categories. The total amount of blood loss is calculated as follows:
Blood collected in calibrated vessel plus soiled pads.
Soiled pads-quarter of pad soiled = 5ml, half of pad soiled = 10ml, ¾ of pad soiled = 20ml, fully soiled pad = 30ml).
The doctor has also observed the time lag between administration of the drug and contraction & retraction of uterus and duration of the third stage of labour (after delivery of baby to complete delivery of placenta).
The observations for duration of third stage of labour are noted in minutes using stop clock. The doctor has also meticulously observed the side effects of the drugs mentioned in literature as well as other untoward effects and note temperature, pulse, BP, Respiration in case records. (Data sheet proforma attached for observations).
Notes on safety & risk reduction
Inj. Oxytocin 10 IU is found to be safe if given i.m. as shown by review of literature. If any patient develops haemorrhage in excess of 500 ml or develops any hemodynamic deterioration, patient shall be managed as per routine therapeutic method immediately using other oxytocic (inj. methyl ergometrine, inj. Carboprost 250mcg tab. Misoprostol 600mcg) surgical methods and intravenous fluids if required to ensure safety of the patient. In present study, Out of total 100 cases 51 patients (51%) belonged to 24-29 years group and 30%belonged to 18-23yrs of group, and 19% belonged to >30 years of age group. Mean age was 25.9 years. Majority 58% of participants belong to urban area, 42% belong to rural area. Since the medical college located in city, majority of patients are from city area. In present study, 53patients (53%) belonged to parity 2, 31% belongs to parity 3 and 16%were of parity 4. Median parity was 2. Mean blood loss in present study group was 119.4 ml. Shivering and nausea were most common side effects of inj. Oxytocin observed during present study. The association between Baby weight and blood loss is statistically considered as extremely significant. As the baby weight increases, the blood loss will also increase.
RESULTS
DISCUSSION
The purpose of the study is to evaluate the efficacy of AMTSL in active management of third stage of labour for prevention of post-partum haemorrhage [by measuring blood loss], duration of 3 rd stage of labour and side effects of oxytocin. The Chi square test was used for comparison between proportions. The main result was a significant reduction of blood loss. We found that Mean blood loss was 119 ml. No maternal deaths caused by PPH were observed during the study period. Incidence of PPH was reduced after the introduction of AMTSL. No maternal deaths caused by PPH were observed during the study period. The association between 3 rd stage of labour and blood loss is statistically considered as extremely significant. Longer the duration of third stage, more will be the blood loss. The association between Baby weight and blood loss is statistically considered as extremely significant. According to earlier research, high birth weight has significant influence on PPH. 18 One patient had PPH and blood transfusion was given after delivery. Shivering was the most common side effect observed during the study. Nausea and vomiting were other side effects observed. No other side effects e.g. water intoxication, hypersensitivity, hypertension was observed during this study. No SAE (serious adverse event) or serious ADR (adverse drug reaction) is reported in our study.
CONCLUSIONS
We recommend that following method must be employed for prevention of Post Partum hemorrhage as tested in our study and also prescribed by WHO 
